| BioCyc:META_PWY-6074 |
zymosterol biosynthesis |
| BioCyc:HUMAN_PWY66-5 |
superpathway of cholesterol biosynthesis |
| BioCyc:HUMAN_PWY66-341 |
cholesterol biosynthesis I |
| BioCyc:YEAST_ERGOSTEROL-SYN-PWY |
superpathway of ergosterol biosynthesis |
| BioCyc:ARA_PWY-2541 |
plant sterol biosynthesis |
| BioCyc:HUMAN_PWY66-3 |
cholesterol biosynthesis II (via 24,25-dihydrolanosterol) |
| BioCyc:HUMAN_PWY-6074 |
zymosterol biosynthesis |
| BioCyc:HUMAN_PWY66-4 |
cholesterol biosynthesis III (via desmosterol) |
| BioCyc:META_ERGOSTEROL-SYN-PWY |
superpathway of ergosterol biosynthesis I |
| BioCyc:YEAST_PWY-6074 |
zymosterol biosynthesis |
| Reactome:R-HSA-9619665 |
EGR2 and SOX10-mediated initiation of Schwann cell myelination |
| Reactome:R-HSA-9675108 |
Nervous system development |
| Reactome:R-BTA-1430728 |
Metabolism |
| Reactome:R-BTA-556833 |
Metabolism of lipids |
| Reactome:R-BTA-191273 |
Cholesterol biosynthesis |
| Reactome:R-BTA-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-DRE-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-DDI-191273 |
Cholesterol biosynthesis |
| Reactome:R-DDI-211859 |
Biological oxidations |
| Reactome:R-HSA-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-HSA-211859 |
Biological oxidations |
| Reactome:R-MMU-1430728 |
Metabolism |
| Reactome:R-MMU-556833 |
Metabolism of lipids |
| Reactome:R-MMU-8957322 |
Metabolism of steroids |
| Reactome:R-MMU-211859 |
Biological oxidations |
| Reactome:R-RNO-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-SCE-8957322 |
Metabolism of steroids |
| Reactome:R-SCE-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-SPO-1430728 |
Metabolism |
| Reactome:R-SPO-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-SSC-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-BTA-8957322 |
Metabolism of steroids |
| Reactome:R-BTA-211859 |
Biological oxidations |
| Reactome:R-DRE-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-DRE-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-DDI-8957322 |
Metabolism of steroids |
| Reactome:R-DDI-211976 |
Endogenous sterols |
| Reactome:R-HSA-1266738 |
Developmental Biology |
| Reactome:R-HSA-556833 |
Metabolism of lipids |
| Reactome:R-HSA-191273 |
Cholesterol biosynthesis |
| Reactome:R-HSA-2426168 |
Activation of gene expression by SREBF (SREBP) |
| Reactome:R-HSA-211976 |
Endogenous sterols |
| Reactome:R-MMU-211976 |
Endogenous sterols |
| Reactome:R-RNO-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-RNO-211859 |
Biological oxidations |
| Reactome:R-SCE-1430728 |
Metabolism |
| Reactome:R-SCE-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-SPO-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-SPO-211859 |
Biological oxidations |
| Reactome:R-SSC-1430728 |
Metabolism |
| Reactome:R-SSC-556833 |
Metabolism of lipids |
| Reactome:R-SSC-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-SSC-211859 |
Biological oxidations |
| Reactome:R-BTA-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-BTA-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-DRE-1430728 |
Metabolism |
| Reactome:R-DRE-556833 |
Metabolism of lipids |
| Reactome:R-DRE-8957322 |
Metabolism of steroids |
| Reactome:R-DRE-211976 |
Endogenous sterols |
| Reactome:R-DDI-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-DDI-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-HSA-6807062 |
Zymostenol biosynthesis via lathosterol (Kandutsch-Russell pathway) |
| Reactome:R-HSA-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-MMU-191273 |
Cholesterol biosynthesis |
| Reactome:R-MMU-211945 |
Phase I - Functionalization of compounds |
| Reactome:R-RNO-1430728 |
Metabolism |
| Reactome:R-RNO-556833 |
Metabolism of lipids |
| Reactome:R-RNO-8957322 |
Metabolism of steroids |
| Reactome:R-RNO-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-SCE-556833 |
Metabolism of lipids |
| Reactome:R-SCE-191273 |
Cholesterol biosynthesis |
| Reactome:R-SCE-211976 |
Endogenous sterols |
| Reactome:R-SPO-8957322 |
Metabolism of steroids |
| Reactome:R-SPO-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-SSC-8957322 |
Metabolism of steroids |
| Reactome:R-SSC-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-BTA-211976 |
Endogenous sterols |
| Reactome:R-DRE-191273 |
Cholesterol biosynthesis |
| Reactome:R-DRE-211859 |
Biological oxidations |
| Reactome:R-DDI-1430728 |
Metabolism |
| Reactome:R-DDI-556833 |
Metabolism of lipids |
| Reactome:R-DDI-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-HSA-1430728 |
Metabolism |
| Reactome:R-HSA-8957322 |
Metabolism of steroids |
| Reactome:R-HSA-1655829 |
Regulation of cholesterol biosynthesis by SREBP (SREBF) |
| Reactome:R-HSA-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-MMU-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-MMU-211897 |
Cytochrome P450 - arranged by substrate type |
| Reactome:R-RNO-191273 |
Cholesterol biosynthesis |
| Reactome:R-RNO-211976 |
Endogenous sterols |
| Reactome:R-SCE-6807047 |
Cholesterol biosynthesis via desmosterol (Bloch pathway) |
| Reactome:R-SCE-211859 |
Biological oxidations |
| Reactome:R-SPO-556833 |
Metabolism of lipids |
| Reactome:R-SPO-191273 |
Cholesterol biosynthesis |
| Reactome:R-SPO-211976 |
Endogenous sterols |
| Reactome:R-SSC-191273 |
Cholesterol biosynthesis |
| Reactome:R-SSC-211976 |
Endogenous sterols |
| WikiPathways:WP5329 |
Cholesterol biosynthesis pathway in hepatocytes |
| WikiPathways:WP4346 |
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways |
| WikiPathways:WP5354 |
Ergosterol biosynthesis |
| PathBank:SMP0121057 |
Bloch Pathway (Cholesterol Biosynthesis) |
| PathBank:SMP0000023 |
Steroid Biosynthesis |
| PathBank:SMP0000387 |
CHILD Syndrome |
| PathBank:SMP0000112 |
Risedronate Action Pathway |
| PathBank:SMP0000508 |
Cholesteryl Ester Storage Disease |
| PathBank:SMP0002438 |
Cholesterol Biosynthesis and Metabolism CE(12:0) |
| PathBank:SMP0000389 |
Smith-Lemli-Opitz Syndrome (SLOS) |
| PathBank:SMP0000319 |
Lysosomal Acid Lipase Deficiency (Wolman Disease) |
| PathBank:SMP0000082 |
Simvastatin Action Pathway |
| PathBank:SMP0000111 |
Cerivastatin Action Pathway |
| PathBank:SMP0000131 |
Atorvastatin Action Pathway |
| PathBank:SMP0000511 |
Wolman Disease |
| PathBank:SMP0002381 |
Steroid Biosynthesis |
| PathBank:SMP0002436 |
Cholesterol biosynthesis and metabolism CE(10:0) |
| PathBank:SMP0002441 |
Cholesterol biosynthesis and metabolism CE(18:0) |
| PathBank:SMP0070041 |
Cholesterol Biosynthesis and Metabolism |
| PathBank:SMP0121060 |
Kandutsch-Russell Pathway (Cholesterol Biosynthesis) |
| PathBank:SMP0000386 |
Desmosterolosis |
| PathBank:SMP0000089 |
Pravastatin Action Pathway |
| PathBank:SMP0000095 |
Alendronate Action Pathway |
| PathBank:SMP0000099 |
Lovastatin Action Pathway |
| PathBank:SMP0000117 |
Pamidronate Action Pathway |
| PathBank:SMP0000509 |
Hyper-IgD Syndrome |
| PathBank:SMP0121236 |
Steroid Biosynthesis |
| PathBank:SMP0000388 |
Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2) |
| PathBank:SMP0000079 |
Ibandronate Action Pathway |
| PathBank:SMP0000092 |
Rosuvastatin Action Pathway |
| PathBank:SMP0000209 |
Hypercholesterolemia |
| PathBank:SMP0000107 |
Zoledronate Action Pathway |
| PathBank:SMP0000119 |
Fluvastatin Action Pathway |
| PathBank:SMP0000510 |
Mevalonic Aciduria |
| PathBank:SMP0002435 |
Cholesterol biosynthesis and metabolism CE(14:0) |
| PathBank:SMP0002440 |
Cholesterol Biosynthesis and Metabolism CE(16:0) |